Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function

checkorphan
Learn more about:
Vaginal cancer
Related Clinical Trial
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance Integrated Cancer Repository for Cancer Research Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer Internet-based System for Cancer Patients to Self-report Toxicity Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy Lymphoscintigraphy in Patients With Vaginal Cancer Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer Pelvic Fractures and Radiation Therapy for Cervical Cancer Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer

Brief Title

Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function

Official Title

Immediate Vaginal Reconstruction Following Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function

Brief Summary

      This study is being done to find out more about the experience women have with vaginal
      reconstruction. We hope to learn about their quality of life, sexual function, and body
      image. We would like to find out how happy women are with surgery. We also want to know what
      things should be changed or improved. Since you have had this surgery, we would like to ask
      you to take part in an interview.

Detailed Description

      The purpose of this study, entitled immediate vaginal reconstruction following oncologic
      resection: Surgical outcomes, patient satisfaction and sexual function is to determine
      postoperative complications, patient satisfaction, quality of life and level of sexual
      functioning among patients who have undergone vaginal reconstruction following tumor
      resection and/or pelvic exenteration.This study will have three components: 1) a chart review
      to determine postoperative complications and anatomic characteristics of the neo-vagina, 2) a
      postoperative questionnaire consisting of validated survey instruments to assess quality of
      life, body image and sexual function and 3) a postoperative qualitative interview to examine
      quality of life after vaginal reconstruction.

Study Type

Interventional

Primary Outcome

To determine perioperative and postoperative complication rates among patients having undergone immediate vaginal reconstruction following tumor resection and/or pelvic exenteration.

Secondary Outcome

 To determine patient satisfaction, quality of life and level of sexual functioning among patients having undergone immediate vaginal reconstruction following tumor resection and/or pelvic exenteration.

Condition

Vaginal Cancer

Intervention

QOL

Study Arms / Comparison Groups

 1
Description:  Participants will receive a cover letter, questionnaire and invitation to participate in a post-operative interview.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status

Behavioral

Estimated Enrollment

27

Start Date

May 2001

Completion Date

August 2016

Primary Completion Date

August 2016

Eligibility Criteria

        Inclusion Criteria:

          -  Immediate partial or total vaginal reconstruction with myocutaneous or fasciocutaneous
             flaps, following pelvic exenteration or tumor resection at MSKCC during the study
             period from January 1, 1993 to, March 30, 2007.

        Exclusion Criteria:

          -  None

Gender

Female

Ages

N/A - N/A

Accepts Healthy Volunteers

No

Contacts

Andrea Pusic, M.D., ,

Location Countries

United States

Location Countries

United States

Administrative Informations

NCT ID

NCT00588081

Organization ID

01-044

Responsible Party

Sponsor

Study Sponsor

Memorial Sloan Kettering Cancer Center

Study Sponsor

Andrea Pusic, M.D., Principal Investigator, Memorial Sloan Kettering Cancer Center

Verification Date

August 2016